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Abstract
Growing evidence supports the concept that immune
reactions occur in the cochlea, where they can function
either in protection or as a source of inflammation. Since
immunity is generally initiated by antigen presentation
of foreign substances to T cells, antigen-presenting cells
expressing major histocompatibility complex (MHC)
class II molecules are required. Under resting conditions,
cochlear cells usually express no MHC class II. However,
we show that exposure to Á-interferon in vitro induces an
increase in MHC class II expression in neonatal cochlear
cells of mice. In addition, MHC class II immunoreactivity
was observed in the inner ear of adult mice after induc-
tion of sterile labyrinthitis in vivo. It is concluded that the
induction of MHC class II molecules by inflammation
may render cochlear cells competent to initiate and par-
ticipate in immune reactions and may therefore contrib-
ute to both immunoprotective and immunopathological
responses of the inner ear.
Copyright © 2002 S. Karger AG, Basel
Introduction
The inner ear was once thought to be a site from which
immune responses were largely excluded, in order to pro-
tect the delicate cells of the inner ear from inflammatory
damage. However, intensive evidence now supports the
participation of immunity in the cochlea [Tomiyama and
Harris, 1987; Takahashi and Harris, 1988; Gloddek et al.,
1991]. Specific immunity has been shown to protect the
inner ear from viral infection [Woolf et al., 1985]. In con-
trast, immune responses are thought to contribute to the
etiology of a growing number of inner ear disorders
[McCabe, 1979; Harris and Sharp, 1990; Arnold et al.,
1987, McKenna, 1997]. Therefore, it is important to elu-
cidate the basic immunological properties of the inner
ear.
The major histocompatibility complex (MHC) class II
molecules play a critical role in induction of an immune
response. These molecules participate in the presentation
of processed antigens to CD4+ T helper cells [Cresswell,
1994]. The localization and identity of antigen-presenting
cells (APCs) that contribute to inner ear immunity have
received relatively little attention. Takahashi and Harris
[1988] indirectly demonstrated the presence of MHC
class II molecules by showing that macrophages invade
the cochlea during an immune response. Altermatt et al.
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[1990] demonstrated the presence of MHC class II in the
normal human endolymphatic sac directly, using anti-
MHC-class-II antibodies. This is consistent with the ob-
servation that reaction to foreign substances and viruses
occurs preferentially in the endolymphatic sac, inducing
endolymphatic hydrops after repeated inflammation
[Tomiyama and Harris, 1987; Gloddek and Harris, 1989;
Tomiyama, 1992]. However, there is evidence from ex-
perimental and clinical data that immunological reactions
of the inner ear are not always associated with endolym-
phatic sac involvement [Hughes et al., 1988; Veldman,
1997]. Even following endolymphatic sac destruction,
specific immunity is observed in the cochlea in response
to antigenic challenge at a reduced level [Tomiyama and
Harris, 1987]. This suggests the presence of APCs in the
cochlea itself.
Á-Interferon (IFN-Á) is a potent inducer of MHC class
II expression in other organs including the brain and
blood vessels [Wong et al., 1984; Kreisel et al., 2001].
Although MHC class II molecules are normally expressed
on professional APCs, such as macrophages and dendritic
cells, expression on other cell types including astrocytes
and endothelial cells can be induced during inflammation
or by cytokines alone [Wong et al., 1984, Cresswell, 1994;
Neumann et al., 1996; Kreisel et al, 2001].
The purpose of the present study was to determine
whether MHC class II antigens can be induced on resident
cells in the cochlea and whether this occurs during coch-
lear inflammatory reactions.
Material and Methods
Experimental Design
The baseline expression of MHC class II glycoproteins was evalu-
ated in cultured cells from the cochlea using cell analysis with a fluo-
rescence-activated cell sorter (FACS) and immunohistochemically in
cochlear sections from mice. Two approaches were used to modify
their levels: treatment with IFN-Á in vitro and induction of sterile
labyrinthitis in vivo.
Animals and Dissection
All procedures were in accordance with the NIH guidelines
regarding animal experimentation and were approved by an animal
subject committee (VAMC, La Jolla, Calif., USA). Postnatal day 3–5
CBA mice were sacrificed, and tissue was dissected as described pre-
viously [Van de Water and Ruben, 1971; Aletsee et al., 2001]. After
anesthesia, the skull was opened midsagittally under sterile condi-
tions and the temporal bone identified after removal of the brain.
Employing a dissection microscope (OPMI 1, Carl Zeiss, Germany),
the membranous labyrinth was exposed after gentle removal of the
cartilaginous cochlear capsule. The lateral wall and the spiral liga-
ment, the organ of Corti as well as the modiolus including the spiral
ganglion and the eighth nerve were dissected and separated from
each other.
Cell Culture
For each tissue type, 8 explants were divided between wells of a
48-well tissue culture plate (Costar), 4 per well. Explants were placed
in Dulbecco’s phosphate-buffered saline (PBS; Gibco) immediately
after dissection. In order to obtain single-cell suspensions, explants
were digested with 1 mg/ml trypsin, 10 mg/ml collagenase and 1 mg/
ml elastase (Sigma, St. Louis, Mo., USA) for 40 min at 37 °C. After
removing the supernatant, 500 Ìl PBS containing 5% fetal calf serum
with Hepes buffer 0.025 M and penicillin 30 U/ml was added per
well. Cell dispersion was obtained by gentle trituration using a 1-ml
syringe with a 25-gauge needle. Spleen and brain served as controls
and were treated identically. One well of each tissue type received
IFN-Á stimulation, while the other well served as unstimulated con-
trol. Stimulation consisted of two doses of 100 IU/ml recombinant
mouse IFN-Á (R&D Systems Inc., USA) in the same media over a
48-hour period. An additional well of spleen cells served as a negative
control for FACS analysis as described below. The entire procedure
was replicated 5 times. In additional cultures, cell survival was evalu-
ated by trypan blue exclusion.
Fluorescent Staining and Flow Cytometric Analysis
After culture in the presence or absence of mouse IFN-Á and
removal of the supernatant, cells were washed and incubated for
30 min at 4°C with fluorescein-isothiocyanate-conjugated rat anti-
mouse MHC class II (I-A/I-E) monoclonal antibody (Pharmingen, La
Jolla, Calif., USA) diluted 1:100 in PBS. Cells were washed twice
with cold PBS and gently detached with 400 Ìl accutase (Innovative
Cell Technologies, San Diego, Calif., USA). Flow cytometric acquisi-
tion of the samples was performed on a Becton-Dickinson FACScan
(San Jose, Calif., USA) using standard Cell Quest acquisition/analy-
sis software. Five thousand live events, which were gated on their
forward/side scatter characteristics, were collected. Autofluorescence
was evaluated in unstimulated spleen cells. The antibody was
replaced by the same volume of PBS followed by FACS analysis. Gat-
ing for positivity of all samples was based on the response of the
unstained spleen cells. The limits of positivity were set such that less
than 1% of the negative control spleen cells were counted. The same
settings were then used for all additional samples.
Induction of Sterile Labyrinthitis in Mice
This procedure has been described in detail in a previous publica-
tion [Takahashi and Harris, 1988]. Mice were immunized subcuta-
neously with the antigen keyhole limpet hemocyanin (KLH; Pacific
Biomarine Supply Co., Venice, Calif., USA) in complete Freund’s
adjuvant and boosted 10 days later with KLH in incomplete
Freund’s adjuvant. For the inner ear challenge, the right middle ear
bulla was opened and the posterior half of the tympanic membrane
removed. A microhole was drilled into the basal turn of the cochlea
and 5 Ìl KLH injected slowly into the cochlea. The hole was sealed
with bone wax. Seven days after the inner ear challenge, the animals
were deeply anesthetized, and intracardiac perfusion with periodate-
lysin-paraformaldehyde fixative was performed. After removal and
decalcification of the temporal bones with 4% EDTA at 4°C, the
tissue was frozen in OCT compound (Tissue Tec, Naperville, Ill.,
USA).
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Immunohistochemistry
The frozen temporal bone was serially sectioned (5–7 Ìm) parallel
to the modiolus. After air-drying of the sections, an indirect immuno-
peroxidase technique was used with the following antibody: goat
antimouse MHC class II (1:50, Santa Cruz Biotechnology, USA)
incubated for 1 h at room temperature. Staining was carried out
employing the test kit Vectastain ABC (Vector Laboratories, Burlin-
game, Calif., USA) using biotinylated rabbit antigoat antibody and
avidin-horseradish-peroxidase. Color reaction was performed with
diaminobenzidine (Vector Laboratories). A light counterstaining
with hematoxylin was performed. As a negative control, the primary
antibody was replaced by goat serum. Murine spleen and subcuta-
neous tissue around the antigen injection site were handled in the
same way and served as positive control tissues.
Statistical Analysis
Statistical analysis, using a nonparametric Mann-Whitney U test
(Statview 5.0), was performed. Differences associated with p values
!0.05 were considered to be statistically significant. All data are pre-
sented as means B standard error.
Fig. 1. Spleen (a), lateral wall (b), organ of
Corti (c), modiolus (d) and spiral ganglion
(e) were harvested and dissociated, and half
of the cells were treated with IFN-Á. Both
populations were then subjected to FACS
analysis to measure MHC class II expres-
sion. A representative run is shown. The
green line in a denotes sorting of spleen cells
with the secondary antibody only as a nega-
tive control. The blue and red lines represent
sorting of untreated or IFN-treated cells, re-
spectively, using both the primary and sec-
ondary antibodies. The x axis depicts fluo-
rescence intensity.
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Fig. 2. Statistical analysis of 5 independent runs of the FACS as illus-
trated in figure 1. Statistical analysis was performed using the Mann-
Whitney U test. Bars represent mean values, standard errors are indi-
cated by lines. SPLØ = Negative control; SPL– = unstimulated
spleen; SPL+ = stimulated spleen; LW– = unstimulated lateral wall;
LW+ = stimulated lateral wall; OC– = unstimulated organ of Corti;
OC+ = stimulated organ of Corti; MOD– = unstimulated modiolus;
MOD+ = stimulated modiolus; SG– = unstimulated spiral ganglion;
SG+ = stimulated spiral ganglion. *p ! 0.01: in each group, the
unstimulated value was compared to the stimulated value.
Results
Cell Culture
The initial number of inner ear cells ranged from 8000
to 12000 per well. The survival rate was about 65–75%
after 48 h in culture, indicated by trypan blue exclusion,
irrespective of the population and IFN-Á stimulation.
FACS Results, Phenotype after Activation
MHC class II molecules were expressed in unstimulat-
ed spleen culture, in a resting state, at a mean value of 5%
with an increase to 33% after IFN-Á treatment (fig. 1a, 2).
On resting inner ear cells, these molecules were expressed
at levels ranging from 3 to 8% (fig. 1b–e). After stimula-
tion with IFN-Á, expression was significantly upregulated
to values between 33 and 53% (fig. 1b–e, 2; p ! 0.01,
Mann-Whitney U test). Figure 2 represents the summa-
rized results of 5 independent runs of the FACS demon-
strating the statistical significant increase in MHC-class-
II-positive cells after stimulation in all tissues.
Immunohistochemical Localization of MHC II
Inflamed subcutaneous tissue stained for MHC class II
revealed intense labeling of scattered cells (fig. 3a). No
MHC class II molecules were detected in the untreated
inner ear (fig. 3b). One week after induction of labyrinthi-
tis, infiltration of a great number of inflammatory cells
into the inner ear was observed (fig. 3c). Approximately
30% of these inflammatory cells were strongly positive for
MHC class II immunoreactivity (fig. 3f). Cells lining the
perilymphatic space and in the spiral ligament also ex-
pressed moderate levels of MHC II after stimulation
(fig. 3d). Interestingly, a few supporting cells of the organ
of Corti (in the region of Hensen’s and Claudius’ cells)
expressed lower levels of MHC class II antigen, as did
neurons of the spiral ganglion (fig. 3e). When the primary
antibody was replaced with goat serum, background stain-
ing was found to be very low in all sections.
Discussion
When dispersed, neonatal cochlear explants of the lat-
eral wall, organ of Corti, modiolus or spiral ganglion were
stimulated with repeated doses of IFN-Á in culture, a sig-
nificant increase in MHC class II molecules was detected
by the FACS in contrast to untreated control cells.
While FACS analysis is an established method in other
experimental fields such as brain or blood vessel research
[Wong et al., 1984; Kreisel et al., 2001], its application for
studies of the inner ear is new. This method has distinct
advantages. These include preservation of antigenicity in
unfixed tissue and the controlled and reproducible stimu-
lation of cells in culture. Disadvantages include the neces-
sity of neonatal tissue, the trauma of tissue dissociation,
changes in cellular characteristics due to culture and cellu-
lar heterogeneity in each portion of the cochlea. For this
reason, the FACS findings were augmented by in vivo
data, employing immunohistochemistry.
Histological localization of MHC class II was achieved
in an established model of inner ear inflammation [Taka-
hashi and Harris, 1988]. No MHC class II was seen in the
normal cochlea. However, after inflammation not only
immigrating immunocompetent cells, but also resident
cochlear cells, including cells lining the perilymph space,
cells of the lateral wall, neurons of the spiral ganglion and
supporting cells of the organ of Corti, expressed MHC
Fig. 3. Immunohistochemical localization of MHC class II mole-
cules in inflamed subcutaneous tissue (a), normal inner ear (b) and
during labyrinthitis (c–f). a Subcutaneous tissue around the KLH
injection site revealing severe inflammation. Arrows depict MHC-
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class-II-positive cells (brown). Scale bar = 25 Ìm. b Normal cochlea
demonstrating only background MHC class II labeling. Scale bar =
100 Ìm. c Cochlear tissue 7 days after induction of labyrinthitis with
labeling of supporting cells and cells of the spiral ligament (arrow) of
the organ of Corti. Scale bar = 50 Ìm. d Strongly MHC-class-II-posi-
tive inflammatory cells in the infiltrate filling the scala tympani (ar-
rows). Scale bar = 100 Ìm. e Labeled neurons of the spiral ganglion
(arrows) in labyrinthitis. Scale bar = 25 Ìm. f MHC-class-II-positive
mesothelial cell (arrow) lining the scala tympani. Scale bar =
100 Ìm.
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class II molecules. These observations were in agreement
with the in vitro results.
The expression of MHC class II molecules on APCs is
an important factor in the process of antigen recognition
by T cells. MHC class II molecules are required for anti-
gen presentation to helper T cells [Cresswell, 1994]. In
this study, we observed a surprisingly high expression of
MHC class II molecules by resident cochlear cells. This
may be related to antigen presentation by these cells as
observed in stimulated neurons of the brain [Wong et al.,
1984; Hart and Fabry, 1995]. Antigen presentation by
resident cells in the vicinity of blood vessels or lining the
perilymph spaces seems to be a reasonable possibility giv-
en the route of lymphocytes into the inner ear during the
immune response [Harris et al., 1990; Gloddek et al.,
1991]. Lymphocytes enter the cochlea via the spiral mod-
iolar vein and enter the perilymph in the scala tympani.
Antigen presentation by spiral ganglion neurons, which
are completely surrounded by Schwann cells, or by sup-
porting cells in the avascular organ of Corti seems less
likely. MHC class II expression in these cells may be relat-
ed to alternative functions of these molecules. For exam-
ple, in the spiral ganglion MHC class II molecules could
be related to the newly discovered guidance function of
MHC molecules for injured neurons, or to the elimination
of synaptic connections in less active neurons [Di Prospe-
ro et al., 1997; Boulanger et al., 2001].
On the normal, in vivo cochlea and in unstimulated
cochlear cells in vitro, we saw little MHC class II expres-
sion. The lack of MHC class II molecules under normal
conditions may be a factor in limiting immune responses,
which could lead to irreversible damage to cochlear cells.
On the other hand, the lack of expression of MHC glyco-
proteins might contribute to the persistence of viruses in
resting cochlear cells. Without MHC on the cell surface,
for example, virally infected neurons of the brain escape
immunological detection and lysis [Joly et al., 1991].
While favorable to the neurons, this allows viruses to per-
sist in these cells. Viral persistence and reactivation has
been suggested as a cause of some forms of sensorineural
hearing loss [Kumagami, 1996; Arnold and Niedermeyer,
1997].
From clinical and experimental studies, it is known
that systemic application of IFN can cause hearing loss.
This has been hypothesized to be caused by metabolic and
biochemical changes in the cochlea [Kanda et al., 1995;
Akyol et al., 2001]. Our results indicate that many cell
types in the cochlea respond to IFN-Á, supporting the idea
that this cytokine has robust biological effects in cochlear
cells.
In conclusion, inflammation leads to an increase in
MHC class II molecule expression in the cochlea. This
could play a role in immune response to infectious agents
or in autoimmune reactions to cochlear proteins. MHC
expression may also participate in other responses of
cochlear cells, such as the reorganization of tissue during
damage [Wierzba-Brobowicz et al., 2000].
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